Business Categories Reports Podcasts Events Webinars
Contact My Account About

BLACKSTONE MAKES MAJORITY INVESTMENT IN ZO SKIN HEALTH

October 9, 2020
October 9, 2020
ZO Skin Health

ZO Skin Health, a skincare brand sold globally through physicians and skincare professionals, closed a majority investment from Blackstone Tactical Opportunities.

WHO: ZO Skin Health develops and delivers innovative skincare solutions that optimize skin health based on the latest advances in skin therapy technologies, unique delivery systems, bioengineered complexes, and exclusive formulations. By providing comprehensive skincare programs for physicians and skincare professionals, ZO bridges the gap between therapeutic treatments and daily care, allowing patients to experience continuously healthy skin regardless of their age, ethnicity, or unique skin condition.

Blackstone is one of the world’s leading investment firms. Tactical Opportunities (Tac Opps) is Blackstone’s opportunistic investment platform. The Tac Opps team invests globally across asset classes, industries, and geographies, seeking to identify and execute on attractive, differentiated investment opportunities. As part of the strategy, the team leverages the intellectual capital across Blackstone’s various businesses while continuously optimizing its approach in the face of ever-changing market conditions.

IN THEIR OWN WORDS: “The Blackstone team supports both my vision of delivering healthy skin to all people and the business potential of the company. Together, we are committed to grow our brand globally and are excited for the next stage of growth for ZO,” said Dr. Zein Obagi.

“On behalf of ZO’s management team, we are thrilled to work with Dr. Zein Obagi and our new partner in Blackstone. We will now have greater resources and tools to help us on our path in becoming the leading global physician-dispensed brand,” said ZO President and CEO Mark Williams.

Todd Hirsch, a Senior Managing Director at Blackstone, said: “ZO Skin Health is one of the fastest-growing brands in the rapidly expanding professional skincare market. We are thrilled to partner with ZO, Dr. Zein Obagi and the management team to continue to serve patients.”

Ram Jagannath, Global Head of Healthcare for Blackstone Growth and Tactical Opportunities, said: “ZO Skin Health’s results-driven products are best-in-class in the physician market, and their position as a trusted skincare brand has made them a market leader and partner to medical professionals. We look forward to investing further in the business to drive growth and believe ZO is well-positioned to continue delivering premier solutions to physicians and patients.”

DETAILS:

  • ZO Skin Health closed a majority investment from Blackstone Tactical Opportunities.
  • The terms of the deal were not disclosed.
  • According to WWD, industry sources said the business is expected to do about $140 million in sales for this year.
  • The brand was created by Zein Obagi, who previously launched the Obagi skincare range in 1988.
  • Financo was the exclusive financial advisor to Blackstone.
×

2 Article(s) Remaining

Subscribe today for full access